Clinical Trial

Topical Carboxytherapy Paste Following Microneedling

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Topical carboxytherapy refers to a gel paste that carries non-gaseous carbon dioxide (CO2). It is applied similarly to a face mask. Topical carboxytherapy has been shown to increase local blood flow and can help with wound healing. Few studies have researched how topical carboxytherapy can be used to aid skin rejuvenation in the field of facial plastic and reconstructive surgery. The goal of this study is to evaluate how topical carboxytherapy can improve skin healing after microneedling. Common temporary side effects of microneedling include redness and swelling, sometimes lasting up to a week post-procedure. If topical carboxytherapy reduces downtime related to side effects of microneedling, the investigators may offer this treatment to more microneedling patients in the future.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-30 -> 2027-06-30 2026-04-15
minor Completion pushed: 2026-06-30 -> 2027-06-30 2026-04-15
Trial Details
NCT Number NCT07431541
Lead Sponsor Vanderbilt University Medical Center
Conditions Skin
Enrollment 20 participants
Start Date 2026-07-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-14